Schedule 13G ownership disclosure
ReShape Lifesciences Inc.
Security class unavailable · CUSIP: 761123504
Event date: 2018-11-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 811,356
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-071423
- Form type
- SC 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Dec 05, 2018
- Reporting period
- Nov 26, 2018
- Description
- Schedule 13G beneficial ownership